Insider · CIK 0001317190

Jeong Tae Heum

Reports to the SEC for 3 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001317190

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-11-04	CLNNClene Inc. · Stock Options (Right to buy)A Award	Chief Finance Officer	AAward	+62.5K sh	—	—	62,500
2021-04-30	CLNNClene Inc. · Stock Options (Right to buy)A Award	Chief Finance Officer	AAward	+20K sh	—	—	20,000
2021-02-01	CLNNClene Inc. · Stock Options (Right to buy)A Award	Chief Finance Officer	AAward	+130K sh	$6.55	+$852K	130,000
2020-01-13	MTVAMetaVia Inc. · Non-qualified stock option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2017-01-20	IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2017-01-20	IRDOpus Genetics, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+63K sh	—	—	63,000
2016-01-28	IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+98.9K sh	—	—	98,853
2016-01-28	IRDOpus Genetics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2015-01-23	IRDOpus Genetics, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+333K sh	—	—	333,332
2015-01-12	IRDOpus Genetics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+49.8K sh	$0.80	+$39.8K	554,800
2015-01-12	IRDOpus Genetics, Inc.S Sale	Chief Financial Officer	SSale	−49.8K sh	$0.91	−$45.5K	505,000
2015-01-12	IRDOpus Genetics, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−49.8K sh	—	—	182,728
2015-01-09	IRDOpus Genetics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+189K sh	$0.80	+$151K	693,690
2015-01-09	IRDOpus Genetics, Inc.S Sale	Chief Financial Officer	SSale	−189K sh	$0.92	−$173K	505,000
2015-01-09	IRDOpus Genetics, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−189K sh	—	—	232,528
2015-01-08	IRDOpus Genetics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+78.8K sh	$0.80	+$63K	583,782
2015-01-08	IRDOpus Genetics, Inc.S Sale	Chief Financial Officer	SSale	−78.8K sh	$0.90	−$70.9K	505,000
2015-01-08	IRDOpus Genetics, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−78.8K sh	—	—	421,218
2014-01-12	IRDOpus Genetics, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2013-09-09	IRDOpus Genetics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+150K sh	$0.24	+$36K	655,000
2013-09-09	IRDOpus Genetics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−78.9K sh	$0.46	−$36K	576,139
2013-09-09	IRDOpus Genetics, Inc.S Sale	Chief Financial Officer	SSale	−71.1K sh	$0.46	−$32.5K	505,000
2013-09-09	IRDOpus Genetics, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−150K sh	—	—	0
2013-03-01	IRDOpus Genetics, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2008-12-11	IRDOpus Genetics, Inc. · Non-statutory stock optionA Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2005-12-08	IRDOpus Genetics, Inc. · Stock option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−100K sh	—	—	150,000
2005-12-08	IRDOpus Genetics, Inc. · Stock option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2005-12-08	IRDOpus Genetics, Inc. · Stock option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−500K sh	—	—	0
2005-12-08	IRDOpus Genetics, Inc. · Stock option (right to buy)A Award	Chief Financial Officer	AAward	+500K sh	—	—	500,000
2005-05-13	IRDOpus Genetics, Inc.A Award	Chief Financial Officer	AAward	+500K sh	—	—	500,000
2005-05-13	IRDOpus Genetics, Inc. · Stock Option: (right to buy)A Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2005-05-13	IRDOpus Genetics, Inc. · Stock Option: (right to buy)A Award	Chief Financial Officer	AAward	+500K sh	—	—	500,000

Recent filings

Accepted (ET)
Nov 44
Jeong Tae Heum0001562180-21-006856
SEC(opens sec.gov)
Apr 304
Jeong Tae Heum0001562180-21-003064
SEC(opens sec.gov)
Feb 34
Jeong Tae Heum0001562180-21-000886
SEC(opens sec.gov)
Jan 154
Jeong Tae Heum0001683168-20-000159
SEC(opens sec.gov)
Jan 244
REXAHN PHARMACEUTICALS, INC.0001140361-17-002737
SEC(opens sec.gov)
Feb 14
REXAHN PHARMACEUTICALS, INC.0001140361-16-049542
SEC(opens sec.gov)
Jan 274
REXAHN PHARMACEUTICALS, INC.0001140361-15-002935
SEC(opens sec.gov)
Jan 124
REXAHN PHARMACEUTICALS, INC.0001140361-15-001483
SEC(opens sec.gov)
Jan 144
REXAHN PHARMACEUTICALS, INC.0001140361-14-002177
SEC(opens sec.gov)
Sep 114
REXAHN PHARMACEUTICALS, INC.0001140361-13-035677
SEC(opens sec.gov)

Companies

Address

C/O REXAHN PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850